Because chronic inflammation drives cancer progression [11,17] and IL-1 is elevated in patient serum, is associated with poor PCa prognosis and a high Gleason score, and promotes PCa metastasis [18,19,20], we sought to determine if chronic IL-1 exposure would also select for viable AR negative/low PCa cells. The gene discussed is IL1A; the disease is cancer.